Is heterogeneity in stage 3 non-small cell lung cancer obscuring the potential benefits of dose-escalated concurrent chemo-radiotherapy in clinical trials?
| Image |  |
|---|---|
| Description | scientific article published on 14 February 2018 |
| Author/s |
author: Corinne Faivre-Finn |
| Publication date | February 14, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |